Merck sees promising results in trial of COVID-19 pill, will apply for emergency approval from FDA
Posted on AllSides October 1st, 2021
From The Right
Merck on Friday said it will seek emergency approval of an antiviral pill to treat COVID-19 after it significantly cut the risk of bad outcomes in clinical trials.
The New Jersey-based drugmaker said the drug, molnupiravir, cut the risk of hospitalization or death in half in high-risk patients with mild to moderate illness.
If authorized for use, it would be a groundbreaking treatment. Pills are easy to take and can reach a wider audience than monoclonal antibodies, an effective treatment in high demand.
Merck said it stopped the trial early in consultation...
Some content from this outlet may be limited or behind a paywall.